These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8436818)

  • 1. Conservation of binding site geometry among p-azophenylarsonate-specific antibodies.
    Parhami-Seren B; Kussie PH; Strong RK; Margolies MN
    J Immunol; 1993 Mar; 150(5):1829-37. PubMed ID: 8436818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of H chain-associated idiotopes of anti-p-azophenylarsonate monoclonal antibodies.
    Parhami-Seren B; Sharon J; Margolies MN
    J Immunol; 1990 Jun; 144(11):4426-33. PubMed ID: 2111347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verification of a model of a F(ab) complex with phenylarsonate by oligonucleotide-directed mutagenesis.
    Sompuram SR; Sharon J
    J Immunol; 1993 Mar; 150(5):1822-8. PubMed ID: 8436817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent somatic mutations in mouse antibodies to p-azophenylarsonate increase affinity for hapten.
    Sharon J; Gefter ML; Wysocki LJ; Margolies MN
    J Immunol; 1989 Jan; 142(2):596-601. PubMed ID: 2911012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of antibody affinity by an engineered amino acid substitution.
    Wong YW; Kussie PH; Parhami-Seren B; Margolies MN
    J Immunol; 1995 Apr; 154(7):3351-8. PubMed ID: 7897218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustered H chain somatic mutations shared by anti-p-azophenylarsonate antibodies confer enhanced affinity and ablate the cross-reactive idiotype.
    Parhami-Seren B; Wysocki LJ; Margolies MN; Sharon J
    J Immunol; 1990 Oct; 145(7):2340-6. PubMed ID: 2118935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the cross-reactive idiotype of the A strain mouse.
    Hasemann CA; Capra JD
    J Immunol; 1991 Nov; 147(9):3170-9. PubMed ID: 1717589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single engineered amino acid substitution changes antibody fine specificity.
    Kussie PH; Parhami-Seren B; Wysocki LJ; Margolies MN
    J Immunol; 1994 Jan; 152(1):146-52. PubMed ID: 8254187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S; Monson N; Ball WJ
    Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural requirements for a specificity switch and for maintenance of affinity using mutational analysis of a phage-displayed anti-arsonate antibody of Fab heavy chain first complementarity-determining region.
    Wong YW; Gill DS; Parhami-Seren B; Short MK; Sompuram SR; Margolies MN
    J Immunol; 1998 Jun; 160(12):5990-7. PubMed ID: 9637513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of idiotype expression in a high-affinity, somatically mutated variant of a germline-encoded anti-p-azobenzenearsonate antibody.
    Nisonoff A; Oliveira TM; Sharon J
    Int Immunol; 1993 Jan; 5(1):1-9. PubMed ID: 8443119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional structure of murine anti-p-azophenylarsonate Fab 36-71. 1. X-ray crystallography, site-directed mutagenesis, and modeling of the complex with hapten.
    Strong RK; Campbell R; Rose DR; Petsko GA; Sharon J; Margolies MN
    Biochemistry; 1991 Apr; 30(15):3739-48. PubMed ID: 2015229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural characterization of idiotopes by using antibody variants generated by site-directed mutagenesis.
    Sharon J
    J Immunol; 1990 Jun; 144(12):4863-9. PubMed ID: 2351832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric antibodies with anti-dextran-derived complementarity-determining regions and anti-p-azophenylarsonate-derived framework regions.
    Kao CY; Sharon J
    J Immunol; 1993 Aug; 151(4):1968-78. PubMed ID: 7688391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of heavy chain junctional amino acid diversity to antibody affinity among p-azophenylarsonate-specific antibodies.
    Parhami-Seren B; Margolies MN
    J Immunol; 1996 Sep; 157(5):2066-72. PubMed ID: 8757328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of an antigen-binding fragment bound to single-stranded DNA.
    Tanner JJ; Komissarov AA; Deutscher SL
    J Mol Biol; 2001 Dec; 314(4):807-22. PubMed ID: 11733999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of a sequence-specific ssDNA binding lupus autoantibody.
    Cleary J; Glick GD
    Biochemistry; 2003 Jan; 42(1):30-41. PubMed ID: 12515537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental analysis by site-directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme.
    Lavoie TB; Drohan WN; Smith-Gill SJ
    J Immunol; 1992 Jan; 148(2):503-13. PubMed ID: 1729369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.